继发于 COVID-19 疫苗接种的免疫性血小板减少症。
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
机构信息
Centro Medico ABC, Ciudad de México, Mexico.
Centro Medico ABC, Ciudad de México, Mexico
出版信息
BMJ Case Rep. 2021 May 31;14(5):e242220. doi: 10.1136/bcr-2021-242220.
Abstract
Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer-BioNTech).
摘要
免疫性血小板减少症（ITP）已被广泛报道为 SARS-CoV-2 感染的并发症，但据我们所知，尚未有关于 COVID-19 疫苗与血小板减少症之间关联的报告。在这里，我们报告了一例最近接种信使 RNA COVID-19 疫苗 BNT162b2（辉瑞-生物科技）的患者发生的继发性 ITP 病例。
相似文献
1
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.继发于 COVID-19 疫苗接种的免疫性血小板减少症。
BMJ Case Rep. 2021 May 31;14(5):e242220. doi: 10.1136/bcr-2021-242220.
2
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].[BNT162b2 mRNA新冠疫苗接种后免疫性血小板减少症]
Rinsho Ketsueki. 2021;62(11):1639-1642. doi: 10.11406/rinketsu.62.1639.
3
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).接种 mRNA COVID-19 疫苗后出现的血小板减少症，包括免疫性血小板减少症，已向疫苗不良事件报告系统（VAERS）报告。
Vaccine. 2021 Jun 8;39(25):3329-3332. doi: 10.1016/j.vaccine.2021.04.054. Epub 2021 Apr 30.
4
A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.BNT162b2 mRNA COVID-19 疫苗接种后免疫性血小板减少症 1 例。
Am J Case Rep. 2021 Jul 21;22:e931478. doi: 10.12659/AJCR.931478.
5
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].[BNT162b2 mRNA新冠疫苗接种后免疫性血小板减少症]
Rinsho Ketsueki. 2021;62(12):1688-1693. doi: 10.11406/rinketsu.62.1688.
6
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.在接种 Vaxzevria ChadOx1-S（阿斯利康）疫苗后发生免疫性血小板减少症，澳大利亚维多利亚州。
Vaccine. 2021 Nov 26;39(48):7052-7057. doi: 10.1016/j.vaccine.2021.10.030. Epub 2021 Oct 30.
7
Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.接种 SARS-CoV-2 疫苗后出现颅内出血和十二指肠出血的免疫性血小板减少性紫癜的成功治疗。
Intern Med. 2022 Jun 15;61(12):1891-1895. doi: 10.2169/internalmedicine.9199-21. Epub 2022 Apr 9.
8
Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.分析全国监测系统报告的 COVID-19 二价加强针接种后血液学不良事件。
Ann Hematol. 2023 Apr;102(4):955-959. doi: 10.1007/s00277-023-05136-2. Epub 2023 Feb 16.
9
A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1 nCoV-19疫苗接种后免疫性血小板减少症1例报告
J Korean Med Sci. 2021 Nov 8;36(43):e306. doi: 10.3346/jkms.2021.36.e306.
10
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.SARS-CoV-2 疫苗相关免疫性血小板减少症患者的治疗、结局和再接种。
Infection. 2023 Feb;51(1):231-238. doi: 10.1007/s15010-022-01909-5. Epub 2022 Oct 4.
引用本文的文献
1
COVID-19-induced immune thrombocytopenia management approach: A case report and literature review.新型冠状病毒肺炎（COVID-19）所致免疫性血小板减少症的管理方法：一例病例报告及文献综述
Clin Case Rep. 2024 Jun 14;12(6):e9070. doi: 10.1002/ccr3.9070. eCollection 2024 Jun.
2
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS).基于mRNA的新型冠状病毒2型疫苗（BNT162b2）接种后的血栓形成——是时候超越血小板减少综合征（TTS）相关血栓形成进行思考了。
Thromb Update. 2022 May;7:100104. doi: 10.1016/j.tru.2022.100104. Epub 2022 Apr 18.
3
A Review of Hematological Complications and Treatment in COVID-19.新型冠状病毒肺炎血液学并发症及其治疗综述
Hematol Rep. 2023 Oct 13;15(4):562-577. doi: 10.3390/hematolrep15040059.
4
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
5
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.COVID-19 疫苗接种相关免疫性血小板减少性紫癜：一项系统评价。
Eur J Haematol. 2023 Apr;110(4):335-353. doi: 10.1111/ejh.13917. Epub 2022 Dec 30.
6
Do we miss rare adverse events induced by COVID-19 vaccination?我们是否遗漏了由新冠病毒疫苗接种引起的罕见不良事件？
Front Med (Lausanne). 2022 Oct 10;9:933914. doi: 10.3389/fmed.2022.933914. eCollection 2022.
7
A Single-Centre Experience of Post-COVID-19 Vaccine-Related Immune-Mediated Complications.新型冠状病毒肺炎疫苗相关免疫介导并发症的单中心经验
Case Rep Hematol. 2022 Sep 30;2022:4742639. doi: 10.1155/2022/4742639. eCollection 2022.
8
A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination.新型冠状病毒肺炎疫苗接种后免疫性血小板减少症报告病例的系统评价
Vaccines (Basel). 2022 Sep 1;10(9):1444. doi: 10.3390/vaccines10091444.
9
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
10
The Frequency and Patterns of Post-COVID-19 Vaccination Syndrome Reveal Initially Mild and Potentially Immunocytopenic Signs in Primarily Young Saudi Women.新冠疫苗接种后综合征的频率和模式显示，在沙特年轻女性中最初表现为轻微且可能有免疫性血细胞减少的体征。
Vaccines (Basel). 2022 Jun 24;10(7):1015. doi: 10.3390/vaccines10071015.
本文引用的文献
1
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.一名22岁接种新冠疫苗后出现的免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.
2
Severe Immune Thrombocytopenia Following MMR Vaccination with Rapid Recovery: A Case Report and Review of Literature.接种麻疹、腮腺炎、风疹疫苗后出现严重免疫性血小板减少症并快速康复：一例报告及文献综述
Int Med Case Rep J. 2020 Dec 15;13:697-699. doi: 10.2147/IMCRJ.S286335. eCollection 2020.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.新型冠状病毒肺炎继发免疫性血小板减少症：一项系统评价
SN Compr Clin Med. 2020;2(11):2048-2058. doi: 10.1007/s42399-020-00521-8. Epub 2020 Sep 19.
5
ITP following vaccination.接种疫苗后发生的免疫性血小板减少症
Int J Infect Dis. 2020 Oct;99:243-244. doi: 10.1016/j.ijid.2020.07.085. Epub 2020 Aug 4.
6
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
7
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.与疫苗接种相关的免疫性血小板减少性紫癜（ITP）：病例报告综述
Immunol Res. 2014 Dec;60(2-3):226-35. doi: 10.1007/s12026-014-8597-x.
8
Vaccine administration and the development of immune thrombocytopenic purpura in children.疫苗接种与儿童免疫性血小板减少性紫癜的发病。
Hum Vaccin Immunother. 2013 May;9(5):1158-62. doi: 10.4161/hv.23601. Epub 2013 Jan 16.
9
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.儿童和成人免疫性血小板减少性紫癜的发病率：已发表报告的批判性回顾。
Am J Hematol. 2010 Mar;85(3):174-80. doi: 10.1002/ajh.21616.
10
Drug-induced thrombocytopenia.药物性血小板减少症
Arch Pathol Lab Med. 2009 Feb;133(2):309-14. doi: 10.5858/133.2.309.
Zotero 插件